Patents by Inventor Neelima Bhagavatula

Neelima Bhagavatula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200261479
    Abstract: An amorphous form of tenofovir alafenamide hemifumarate and process for the preparation of the same. A premix of amorphous tenofovir alafenamide hemifumarate with pharmaceutically acceptable excipients and process for the preparation of the same are also disclosed.
    Type: Application
    Filed: December 18, 2019
    Publication date: August 20, 2020
    Applicant: MYLAN LABORATORIES LIMITED
    Inventors: Ramakoteswara Rao Jetti, Amit Singh, Neelima Bhagavatula, Anjaneyaraju Indukuri, B. A. Ramireddy
  • Patent number: 10562866
    Abstract: The amorphous form of trisodium sacubitril valsartan and methods for the preparation thereof are disclosed herein.
    Type: Grant
    Filed: February 6, 2016
    Date of Patent: February 18, 2020
    Assignee: Mylan Laboratories Limited
    Inventors: Vellanki Sivaram Prasad, Arabinda Sahu, Siva Koteswara Rao Prathi, Lakshmana Rao Ampolu, Ramakoteswara Rao Jetti, Aggi Ramireddy Bommareddy, Neelima Bhagavatula, Nitin Ashok Shimpi
  • Patent number: 10479782
    Abstract: The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: November 19, 2019
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, AnJaneyaraju Indukuri, Bommareddy Aggiramireddy, Neelima Bhagavatula, Amit Singh, Soumyajit Ghosh, Attanti Veera Venkata Srinivasarao, Umasankara Sastry Tummalapalli, Veera Venkata Satya Surya Appala Gosula
  • Publication number: 20190055224
    Abstract: The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.
    Type: Application
    Filed: September 28, 2016
    Publication date: February 21, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, AnJaneyaraju Indukuri, Bommareddy Aggiramireddy, Neelima Bhagavatula, Amit Singh, Soumyajit Ghosh, Attanti Veera Venkata Srinivasarao, Umasankara Sastry Tummalapalli, Veera Venkata Satya Surya Appala Gosula
  • Publication number: 20180273493
    Abstract: The amorphous form of trisodium sacubitril valsartan and methods for the preparation thereof are disclosed herein.
    Type: Application
    Filed: February 6, 2016
    Publication date: September 27, 2018
    Applicant: Mylan Laboratories Limited
    Inventors: Vellanki Sivaram Prasad, Arabinda Sahu, Siva Koteswara Rao Prathi, Lakshmana Rao Ampolu, Ramakoteswara Rao Jetti, Aggi Ramireddy Bommareddy, Neelima Bhagavatula, Nitin Ashok Shimpi, Manisha Singh
  • Publication number: 20170348334
    Abstract: An amorphous form of tenofovir alafenamide hemifumarate and process for the preparation of the same. A premix of amorphous tenofovir alafenamide hemifumarate with pharmaceutically acceptable excipients and process for the preparation of the same are also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: December 7, 2017
    Inventors: Amit Singh, AggiRamireddy Bommareddy, Neelima Bhagavatula, Anjaneyaraju Indukuri, Kiran MItchanagatla, Padala Subbarayudu
  • Patent number: 8993786
    Abstract: The main object of the present invention relates to a novel crystalline form of Fosemprenavir Calcium designated as Form A. Another object of the present invention relates to a process for the preparation of Crystalline Form A of Fosemprenavir Calcium. Yet another object of the present invention relates to crystalline Forma A of Fosemprenavir Calcium characterized by a PXRD diffraction having reflections at about 3.1±0.2, 4.4±0.2, 5.0±0.2, 6.3±0.2, 7.4±0.2, 8.0±0.2, 2?.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: March 31, 2015
    Assignee: Mylan Laboratories Ltd.
    Inventors: Ramakoteswara Rao Jetti, Neelima Bhagavatula, Asha Rani Gorantla
  • Publication number: 20130317236
    Abstract: The main object of the present invention relates to novel crystalline form of Fosamprenavir Calcium designated as Form A. Another object of the present invention relates to a process for the preparation of Crystalline Form A of Fosamprenavir Calcium. Yet another object of the present invention relates to crystalline Form A of Fosamprenavir Calcium characterized by an PXRD diffraction having reflections at about 3.1±0.2, 4.4±0.2, 5.0±0.2, 6.3±0.2, 7.4±0.2, 8.0±0.2, 28.
    Type: Application
    Filed: February 9, 2012
    Publication date: November 28, 2013
    Applicant: MYLAN LABORATORIES LTD.
    Inventors: Ramakoteswara Rao Jetti, Neelima Bhagavatula, Asha Rani Gorantla